High-Tech Gründerfonds (HTGF) and the investment arm of Life Science Inkubator have invested in German epigenetics specialist Epivios, alongside Technology Transfer Heinrich Heine University and a private investor.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy